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Center Mission
Translate basic neurobehavioral research 
findings into small-scale efficacy trials to 
enhance the impact of anti-drug 
prevention messages.
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Sensation Seeking
Personality trait characterized by a need for 
novel, complex, ambiguous and emotionally 
intense stimuli and by a willingness to take 
risks to obtain such stimulation.
(Zuckerman, 1988)
Sensation Seeking and % Drug Use In Last 30 Days Among 
Junior and Senior High School Students in Fayette County
Drug 
Category
Grade
6-8
Low SS
(n=658)
Grade
6-8
High SS
(n=565)
Grade
9-12
Low SS
(n=450)
Grade
9-12
High SS
(n=420)
Marijuana 6.2 24.7 13.0 38.3
Cocaine 0.6 3.4 1.8 6.6
Liquor 20.7 58.3 28.5 67.1
Beer 24.9 58.3 38.0 70.5
Stimulants 1.4 14.9 2.0 14.8
Sedatives 0.5 11.2 1.6 6.6
Hypothesis
High sensation seekers are biologically 
predisposed to be at risk for drug abuse.
VTA
NAcc NAcc
ACC
OFC
Pit
PVN
Amyg
ACTH
adrenal
gland
cortisol
Reward System Inhibition System Stress System
mPFC = medial prefrontal cortex NAcc = nucleus accumbens
VTA = ventral tegmental area ACC = anterior cingulate cortex
OFC = orbitofrontal cortex PVN = paraventricular nucleus 
Pit = pituitary gland Amyg = amygdala 
ACTH = adrenocorticotropic hormone
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“Sensation Seeking” in Rats
Drug Self-Administration Method
•Male Sprague-Dawley rats, 250-350 g.
•Food restriction to 85% normal body weight   
•Shape to lever press for sucrose pellet
•Free feed for one week
•Implant jugular catheter
•One week recovery
•Initiate drug self-administration 
All procedures approved by University of Kentucky IACUC and 
conformed to NIH Guide (1996).
High Novelty Responders Self-Administer 
More Amphetamine Than Low Novelty Responders 
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Enhanced Amphetamine Self-Administraiton in High 
Responders Involves the Central Nucleus of Amygdala
Novelty Seeking and Amphetamine Self-
Administration are Linked Genetically
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Environmental Influence in Relation Between 
Novelty Seeking and Amphetamine Reward
Enriched Condition (EC) Isolated Condition (IC)
GET ENRICHED!!!
IC Rats Respond More for Novel Visual Stimulus
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IC Rats Self-Administer More Amphetamine 
on PR Schedule
IC Rats have Greater Amphetamine-induced 
Increase in Plasma Corticosterone 
15 min 180 min 60 min 
IC Rats have Increased Basal Tissue DOPAC 
Levels in mPFC, but not in Striatum or 
Nucleus Accumbens
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IC Rats have Increased DAT Function 
in Prefrontal Cortex Compared to EC Rats
Summary from Preclinical Experiment in Rats 
 Relationship between novelty seeking and 
amphetamine self-administration is determined by both 
genetic and environmental factors.
 High novelty seekers  are more sensitive to the 
reinforcing effect of amphetamine.
 High novelty seekers have a deficit in inhibitory 
control.
 High novelty seekers have overactive stress axis, which 
may involve alterations in amygdala and prefrontal 
cortex. 
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High Sensation Seekers Like 
Amphetamine More than Low Sensation 
Seekers
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Hypothesis
 If high sensation stimuli and drugs of abuse 
activate common brain systems…
 …then brain reactivity to high sensation stimuli 
will be greater in high sensation seekers than in 
low sensation seekers.
• Novelty Detection
• Emotional Arousal
Explore responses to emotional
content
During brain 
imaging 
session, view a 
series of 
pictures
Low arousal, 
positive valence
High arousal, 
positive valence
Low arousal, 
negative valence
High arousal, 
negative valence
Press a button 
each time a 
picture appears
High Sensation Seekers Low Sensation Seekers
Right Insula: 
Autonomic 
arousal, 
cravings
High Sensation Seekers Low Sensation Seekers
Left ACC: 
Emotional 
regulation, 
cognitive 
control
Summary of Controlled Experiments with 
Human Subjects
 Abuse liability of d-amphetamine is greater 
in high sensation seekers.
 With emotionally arousing images:
• High sensation seekers engage arousal 
region (insula) quickly, followed by 
emotional regulation region (anterior 
cingulate cortex).
• Low sensation seekers engage primarily 
emotional regulation region only (anterior 
cingulate cortex).
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Communication Connection
 Sensation seeking and message 
sensation value
Message Sensation Value
 Novel, creative, or 
unusual
 Intense (strong sound 
and visual effects)
 Emotionally strong
 Physically Arousing 
(exciting, stimulating)
 Fast-paced
 Graphic or explicit
 Absence of 
“preaching”
 Unconventional
High Sensation-Seekers tend to prefer
the following message characteristics:
2-City Anti-Marijuana
Campaign Study:
Message Content Targeted HSS
 PSAs focused on scientifically-documented 
negative consequences of marijuana use
that HSS teens saw as important (in focus 
group research)
• Damaged relationships with family and friends
• Decreased academic and sports performance
• Loss of part-time jobs
• Impaired memory and judgments
• Reduced motivation
• Depression
• Lung damage
“Michael”
“Downer”


Safer Sex Mass Media Campaign 
Targeting Young Adults
“My Story 2”
“Translation”
Preliminary Study: Brain Response to Anti-
Drug and Safe Sex PSA’s
HSS>LSS in temporal poles        HSS<LSS in hippocampus
High SS
Low SS
(a) (c) (e)
(b) (d) (f)
• Marijuana use can be significantly reduced 
among adolescents
• Condom use can be increased among young 
adults
• Preliminary results suggest that high 
sensation value anti-drug and safe sex PSAs 
produce greater frontal pole activation and 
less hippocampal activation among high 
sensation seekers
Summary from Translational Field-Based 
Experiments
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